SCHEMBL21292691

SCHEMBL21292691

O=C(NN=Cc1cccc(O)c1)c1ccc(O)cc1O

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.80
MEN1 O00255 5/20 0.77
KMT2A Q03164 5/20 0.77
POLB P06746 3/20 0.77
GFER P55789 1/20 0.66
RRM1 P23921 1/20 0.62
ALDH1A1 P00352 1/20 0.62
CYP2D6 P10635 1/20 0.61
GCGR P47871 1/20 0.61
CA12 O43570 1/20 0.60
CA1 P00915 1/20 0.60
CA2 P00918 1/20 0.60
CA9 Q16790 1/20 0.60
NTRK1 P04629 2/20 0.59
MAPT P10636 1/20 0.56
HTT P42858 1/20 0.56
CASP3 P42574 1/20 0.55
SENP8 Q96LD8 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
SENP6 Q9GZR1 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21292689 1.00 NPSR1 (0.80) NPSR1MEN1KMT2APOLBGFER
SCHEMBL20115424 0.90 MEN1 (0.75) NPSR1MEN1KMT2APOLBRRM1
SCHEMBL20299057 0.90 MEN1 (0.75) NPSR1MEN1KMT2APOLBRRM1
SCHEMBL21292666 0.89 MEN1 (0.67) NPSR1MEN1KMT2APOLBGFER
SCHEMBL21292668 0.89 MEN1 (0.67) NPSR1MEN1KMT2APOLBGFER
SCHEMBL20115428 0.87 MEN1 (0.63) NPSR1MEN1KMT2APOLBGFER
SCHEMBL21292852 0.87 MEN1 (0.63) NPSR1MEN1KMT2APOLBGFER
SCHEMBL14448892 0.86 NTRK1 (0.72) NPSR1MEN1KMT2APOLBGFER
SCHEMBL21292762 0.85 PHGDH (0.70) NPSR1MEN1KMT2APOLBALDH1A1
SCHEMBL21292765 0.85 PHGDH (0.70) NPSR1MEN1KMT2APOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof PEKING UNIVERSITY (CN) 2020-07-28 US disclosed
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2019-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof MDH2, MDH1, DLD NPSR1 4875/4885MEN1 2502/4885KMT2A 1899/4885
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD NPSR1 4875/4885MEN1 2502/4885KMT2A 1899/4885
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD NPSR1 4875/4885MEN1 2502/4885KMT2A 1899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.